EE200000788A - Ravimi läbimiskiirust kontrolliv membraan või maatriks - Google Patents

Ravimi läbimiskiirust kontrolliv membraan või maatriks

Info

Publication number
EE200000788A
EE200000788A EEP200000788A EEP200000788A EE200000788A EE 200000788 A EE200000788 A EE 200000788A EE P200000788 A EEP200000788 A EE P200000788A EE P200000788 A EEP200000788 A EE P200000788A EE 200000788 A EE200000788 A EE 200000788A
Authority
EE
Estonia
Prior art keywords
matrix
flow rate
rate controlling
controlling membrane
drug flow
Prior art date
Application number
EEP200000788A
Other languages
English (en)
Inventor
Jukarainen Harri
Markkula Tommi
Ala-Sorvari Juha
Lehtinen Matti
Ruohonen Jarkko
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of EE200000788A publication Critical patent/EE200000788A/et
Publication of EE04685B1 publication Critical patent/EE04685B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/10—Block- or graft-copolymers containing polysiloxane sequences
    • C08L83/12—Block- or graft-copolymers containing polysiloxane sequences containing polyether sequences
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0039—Devices retained in the uterus for a prolonged period, e.g. intrauterine devices for contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • Silicon Polymers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Wrappers (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Materials For Medical Uses (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
EEP200000788A 1998-06-30 1999-06-11 Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks EE04685B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI981506A FI107339B (fi) 1998-06-30 1998-06-30 Lääkeaineiden läpäisynopeutta säätävä kalvo tai matriisi
PCT/FI1999/000511 WO2000000550A1 (en) 1998-06-30 1999-06-11 A membrane or matrix for controlling the permeation rate of drugs

Publications (2)

Publication Number Publication Date
EE200000788A true EE200000788A (et) 2002-04-15
EE04685B1 EE04685B1 (et) 2006-08-15

Family

ID=8552104

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000788A EE04685B1 (et) 1998-06-30 1999-06-11 Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks

Country Status (28)

Country Link
EP (1) EP1124902B1 (et)
JP (1) JP2002519467A (et)
KR (1) KR100599868B1 (et)
CN (2) CN1176999C (et)
AR (1) AR018952A1 (et)
AT (1) ATE290049T1 (et)
AU (1) AU752895B2 (et)
BG (1) BG65148B1 (et)
BR (1) BR9911140B1 (et)
CA (1) CA2336149C (et)
CO (1) CO5060523A1 (et)
CZ (1) CZ299613B6 (et)
DE (1) DE69923992T2 (et)
EE (1) EE04685B1 (et)
ES (1) ES2237120T3 (et)
FI (1) FI107339B (et)
HU (1) HU229159B1 (et)
NO (1) NO327955B1 (et)
NZ (1) NZ508275A (et)
PE (1) PE20000935A1 (et)
PL (1) PL193485B1 (et)
PT (1) PT1124902E (et)
RU (1) RU2201794C2 (et)
SK (1) SK285325B6 (et)
TW (1) TWI237571B (et)
UA (1) UA71566C2 (et)
WO (1) WO2000000550A1 (et)
ZA (1) ZA200006986B (et)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476079B1 (en) * 1999-12-23 2002-11-05 Leiras Oy Devices for the delivery of drugs having antiprogestinic properties
AU2002210580A1 (en) * 2000-10-20 2002-04-29 Leiras Oy Drug delivery system
EP1438942A1 (en) * 2003-01-17 2004-07-21 Schering Oy An otorhinological drug delivery device
CN101006124B (zh) * 2004-08-25 2010-11-24 联合碳化化学及塑料技术有限责任公司 聚合薄膜
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
RU2461584C2 (ru) 2007-03-12 2012-09-20 Байер Ой Применение токоферола
EP2140860A1 (en) 2008-07-03 2010-01-06 Bayer Schering Pharma Oy An improved method of contraception
FI20080524A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
FI20080523A0 (fi) 2008-09-17 2008-09-17 Bayer Schering Pharma Oy Insertteri
CN102159162B (zh) 2008-09-17 2013-04-24 拜耳公司 插入器
US11992431B2 (en) 2008-09-17 2024-05-28 Bayer Oy Inserter
FI122579B (fi) 2010-10-29 2012-03-30 Bayer Oy Insertteri
CN102008909B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
CN102068914B (zh) * 2010-12-13 2012-10-10 大连欧科膜技术工程有限公司 一种气体分离复合膜的制备方法
JP2015514789A (ja) 2012-04-23 2015-05-21 バイエル・ファルマ・アクチェンゲゼルシャフトＢａｙｅｒ Ｐｈａｒｍａ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ 過多月経症の処置における１８−メチル−１５β，１６β−メチレン−１９−ノル−２０−スピロキサ−４−エン−３−オンの使用、ならびに子宮出血障害の処置のための１８−メチル−１５β，１６β−メチレン−１９−ノル−２０−スピロキサ−４−エン−３−オンを含有する子宮内システム
TW201350122A (zh) 2012-04-23 2013-12-16 Bayer Pharma AG １８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內用途，包含１８－甲基－１５β，１６β－亞甲基－１９－降－２０－螺氧－４－烯－３－酮的子宮內系統，及其於避孕及婦科治療之用途
US20160262923A1 (en) * 2013-10-18 2016-09-15 Bayer Oy Intrauterine delivery system
ES3009909T3 (en) 2015-05-13 2025-03-31 Bayer Oy Long acting drug delivery device in form of an implant or iud comprising levonorgestrel and ethinylestradiol
WO2018202574A1 (en) 2017-05-04 2018-11-08 Bayer Oy Intravaginal drug delivery system, method for manufacturing such system and its use in gynecological therapies and contraception
CA3085959A1 (en) 2017-12-22 2019-06-27 Alyra Biotech Pty Ltd Treatment of pain and/or pain related symptoms associated with dysmenorrhea
EP3536735B1 (de) * 2018-03-05 2020-10-14 Evonik Operations GmbH Vernetzte polyether-siloxan block-copolymere sowie deren verwendung zur herstellung von polyurethanschaumstoffen
AU2020282388B2 (en) 2019-05-31 2026-01-29 Alyra Biotech Pty Ltd Methods, compositions and devices for treating neuroinflammatory conditions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889108A (en) * 1997-06-02 1999-03-30 Dow Corning Corporation Thickening solvents with elastomeric silicone polyethers

Also Published As

Publication number Publication date
BR9911140B1 (pt) 2009-08-11
AR018952A1 (es) 2001-12-12
TWI237571B (en) 2005-08-11
AU4783999A (en) 2000-01-17
SK18942000A3 (sk) 2001-07-10
KR100599868B1 (ko) 2006-07-12
PT1124902E (pt) 2005-07-29
PL345103A1 (en) 2001-12-03
DE69923992T2 (de) 2006-04-13
FI981506A0 (fi) 1998-06-30
NO20006581D0 (no) 2000-12-21
KR20010053346A (ko) 2001-06-25
CN1488678A (zh) 2004-04-14
DE69923992D1 (de) 2005-04-07
HUP0102600A2 (hu) 2001-11-28
HU229159B1 (hu) 2013-09-30
CZ20004749A3 (cs) 2001-10-17
NO20006581L (no) 2000-12-29
CA2336149C (en) 2007-01-02
SK285325B6 (sk) 2006-11-03
FI107339B (fi) 2001-07-13
NO327955B1 (no) 2009-10-26
EP1124902A1 (en) 2001-08-22
ATE290049T1 (de) 2005-03-15
NZ508275A (en) 2002-09-27
ZA200006986B (en) 2001-05-23
WO2000000550A1 (en) 2000-01-06
CN1176999C (zh) 2004-11-24
CN1269909C (zh) 2006-08-16
JP2002519467A (ja) 2002-07-02
EP1124902B1 (en) 2005-03-02
BR9911140A (pt) 2001-03-06
HUP0102600A3 (en) 2004-04-28
CN1308653A (zh) 2001-08-15
PE20000935A1 (es) 2000-09-18
CA2336149A1 (en) 2000-01-06
FI981506L (fi) 1999-12-31
HK1038939A1 (en) 2002-04-04
BG65148B1 (bg) 2007-04-30
RU2201794C2 (ru) 2003-04-10
ES2237120T3 (es) 2005-07-16
EE04685B1 (et) 2006-08-15
BG105081A (en) 2001-09-28
PL193485B1 (pl) 2007-02-28
AU752895B2 (en) 2002-10-03
CO5060523A1 (es) 2001-07-30
UA71566C2 (uk) 2004-12-15
CZ299613B6 (cs) 2008-09-17

Similar Documents

Publication Publication Date Title
DE69841253D1 (de) Medizinisches durchflussregelventil
DE50007502D1 (de) Durchflussmengenregler
DE69939110D1 (de) Fluidstromsteuerungsanlage
EE200100257A (et) Uudne membraan või maatriks ravimi läbitungimise kontrollimiseks
DE60016167D1 (de) Durchflussmengenschaltvorrichtung
DE10196953T1 (de) Druckbasiertes Massenfluss-Steuersystem
DE69820677D1 (de) Mikrokapseln mit einfach einstellbarer abgaberate
DE69808558D1 (de) Pädiatrisches, programmierbares Hydrocephalusventil
DE50012712D1 (de) Fluidtechnisches Steuergerät
DE69838955D1 (de) Implantat mit durchflussregelung
ID29539A (id) Pengontrol aliran
DE50008631D1 (de) Fluidisches Steuerelement
DE19983651T1 (de) Fluidsteuerung
DE69731369D1 (de) Durchflussregelventil
DE60024283D1 (de) Durchflussscheibe mit temperaturmerkmal
DK0962209T3 (da) Trykreguleringssystem
EE04685B1 (et) Ravimi l„bimiskiirust kontrolliv membraan v?i maatriks
DE19983997T1 (de) Fluidsteuerung
DE60334712D1 (de) Durchflusssteuerungssystem
IT1303875B1 (it) Dispositivo di controllo di portata d'acqua con mezzi di rilasciodi pressione
DE60007048D1 (de) Durchflussreguliergerät
FI980564A7 (fi) Virtausputken määränsäätöelin
DE69837538D1 (de) Motorisierte durchflussregelventil
DE69725762D1 (de) Implantierbares,einstellbares durchflusskontrolventil
DE60202734D1 (de) Durchflussregelventilsystem

Legal Events

Date Code Title Description
HC1A Change of owner name
KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20150611